Levant

Lansoprazole, the active ingredient in Levant, is a proton pump inhibitor presented as an oral formulation for oral use. It reduces gastric acid production and is employed in the management of conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, Helicobacter pylori eradication regimens, and erosive esophagitis.

GNH USA supplies Levant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levant, a proton pump inhibitor, is used to manage acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing gastric acidity. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression. - Helicobacter pylori eradication: enhances antibiotic effectiveness by creating a less acidic gastric environment. - Erosive esophagitis: facilitates mucosal healing by decreasing exposure to gastric acid.

Levant may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of stomach upset or queasiness. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridium difficile infection: severe diarrhea with abdominal pain. - Stevens‑Johnson syndrome: skin blistering and mucosal involvement. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Pancreatitis: upper abdominal pain radiating to the back.

Before initiating Levant, consider the following precautions to ensure safe use. - Assess renal function: adjust therapy in patients with severe impairment. - Monitor hepatic disease: use with caution in liver dysfunction. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Caution in osteoporosis risk: long‑term use may affect bone density. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Levant can interact with several medications, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising antiviral therapy. - High‑dose methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: altered serum levels, may need dose adjustment. - Diazepam: increased sedation, monitor for excessive CNS depression.